Descriptor English: | Megestrol Acetate | ||||
Descriptor Spanish: |
Acetato de Megestrol
| ||||
Descriptor Portuguese: | Acetato de Megestrol | ||||
Descriptor French: | Acétate mégestrol | ||||
Entry term(s): |
Acetate, Megestrol Apo Megestrol Apo-Megestrol ApoMegestrol Borea Lin Megestrol Lin-Megestrol LinMegestrol Maygace Megace Megefren Megestat Megostat Mestrel Nu Megestrol Nu-Megestrol NuMegestrol |
||||
Tree number(s): |
D04.210.500.745.432.531.500 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019290 | ||||
Scope note: | Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antineoplastic Agents, Hormonal Appetite Stimulants |
||||
Registry Number: | TJ2M0FR8ES | ||||
CAS Type 1 Name: | Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl- | ||||
Previous Indexing: |
Megestrol/analogs & derivatives (1980-1996) |
||||
Public MeSH Note: | 97 |
||||
History Note: | 97; |
||||
DeCS ID: | 33000 | ||||
Unique ID: | D019290 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1997/01/01 | ||||
Date of Entry: | 1996/06/10 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Megestrol Acetate
- Preferred
Lin-Megestrol
- Narrower
Maygace
- Narrower
Megace
- Narrower
Megefren
- Narrower
Mestrel
- Narrower
Nu-Megestrol
- Narrower
Borea
- Narrower
Apo-Megestrol
- Narrower
Concept UI |
M0028721 |
Scope note | Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) |
Preferred term | Megestrol Acetate |
Entry term(s) |
Acetate, Megestrol |
Concept UI |
M0473933 |
Preferred term | Lin-Megestrol |
Entry term(s) |
Lin Megestrol LinMegestrol |
Concept UI |
M0473934 |
Preferred term | Maygace |
Concept UI |
M0028722 |
Preferred term | Megace |
Entry term(s) |
Megestat Megostat |
Concept UI |
M0473935 |
Preferred term | Megefren |
Concept UI |
M0473936 |
Preferred term | Mestrel |
Concept UI |
M0473937 |
Preferred term | Nu-Megestrol |
Entry term(s) |
Nu Megestrol NuMegestrol |
Concept UI |
M0473932 |
Preferred term | Borea |
Concept UI |
M0473931 |
Preferred term | Apo-Megestrol |
Entry term(s) |
Apo Megestrol ApoMegestrol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey